John G. Schulte

Restore Medical developed, manufactured and marketed pillar palatal implant systems used for the treatment of soft palate components of sleeps disordered breathing, obstructive sleep apnea, and snoring. The company was founded in 1999 and was headquartered in St. Paul, MN.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Restore Medical developed, manufactured and marketed pillar palatal implant systems used for the treatment of soft palate components of sleeps disordered breathing, obstructive sleep apnea, and snoring. The company was founded in 1999 and was headquartered in St. Paul, MN.

Restore Medical developed, manufactured and marketed pillar palatal implant systems used for the treatment of soft palate components of sleeps disordered breathing, obstructive sleep apnea, and snoring. The company was founded in 1999 and was headquartered in St. Paul, MN.

Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA.

Restore Medical developed, manufactured and marketed pillar palatal implant systems used for the treatment of soft palate components of sleeps disordered breathing, obstructive sleep apnea, and snoring. The company was founded in 1999 and was headquartered in St. Paul, MN.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Restore Medical developed, manufactured and marketed pillar palatal implant systems used for the treatment of soft palate components of sleeps disordered breathing, obstructive sleep apnea, and snoring. The company was founded in 1999 and was headquartered in St. Paul, MN.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Somnus Medical Technologies, Inc. designs, develops, manufactures, and markets medical devices. Its products utilizes proprietary temperature-controlled radiofrequency technology for the treatment of upper airway disorders in a procedure called somnoplasty. The company was founded on April 9, 1996 and is headquartered in Sunnyvale, CA.

Somnus Medical Technologies, Inc. designs, develops, manufactures, and markets medical devices. Its products utilizes proprietary temperature-controlled radiofrequency technology for the treatment of upper airway disorders in a procedure called somnoplasty. The company was founded on April 9, 1996 and is headquartered in Sunnyvale, CA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Restore Medical developed, manufactured and marketed pillar palatal implant systems used for the treatment of soft palate components of sleeps disordered breathing, obstructive sleep apnea, and snoring. The company was founded in 1999 and was headquartered in St. Paul, MN.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Restore Medical developed, manufactured and marketed pillar palatal implant systems used for the treatment of soft palate components of sleeps disordered breathing, obstructive sleep apnea, and snoring. The company was founded in 1999 and was headquartered in St. Paul, MN.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Restore Medical developed, manufactured and marketed pillar palatal implant systems used for the treatment of soft palate components of sleeps disordered breathing, obstructive sleep apnea, and snoring. The company was founded in 1999 and was headquartered in St. Paul, MN.

Restore Medical developed, manufactured and marketed pillar palatal implant systems used for the treatment of soft palate components of sleeps disordered breathing, obstructive sleep apnea, and snoring. The company was founded in 1999 and was headquartered in St. Paul, MN.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Restore Medical developed, manufactured and marketed pillar palatal implant systems used for the treatment of soft palate components of sleeps disordered breathing, obstructive sleep apnea, and snoring. The company was founded in 1999 and was headquartered in St. Paul, MN.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Restore Medical developed, manufactured and marketed pillar palatal implant systems used for the treatment of soft palate components of sleeps disordered breathing, obstructive sleep apnea, and snoring. The company was founded in 1999 and was headquartered in St. Paul, MN.

Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.